Eglal I. Amer

636 total citations
24 papers, 471 citations indexed

About

Eglal I. Amer is a scholar working on Parasitology, Public Health, Environmental and Occupational Health and Ecology. According to data from OpenAlex, Eglal I. Amer has authored 24 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Parasitology, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Ecology. Recurrent topics in Eglal I. Amer's work include Parasites and Host Interactions (15 papers), Research on Leishmaniasis Studies (11 papers) and Parasite Biology and Host Interactions (8 papers). Eglal I. Amer is often cited by papers focused on Parasites and Host Interactions (15 papers), Research on Leishmaniasis Studies (11 papers) and Parasite Biology and Host Interactions (8 papers). Eglal I. Amer collaborates with scholars based in Egypt, United Kingdom and Libya. Eglal I. Amer's co-authors include Maha M. Eissa, Shereen F. Mossallam, Mervat Z. El‐Azzouni, Nahed Baddour, Labiba K. El‐Khordagui, Riham M. El‐Moslemany, Alyaa A. Ramadan, Iman F. Abou-El-Naga, Hoda Mahrous and Ashraf Barakat and has published in prestigious journals such as PLoS ONE, PLoS neglected tropical diseases and International Journal for Parasitology.

In The Last Decade

Eglal I. Amer

24 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eglal I. Amer Egypt 13 273 177 119 78 75 24 471
Mervat Z. El‐Azzouni Egypt 11 239 0.9× 116 0.7× 91 0.8× 79 1.0× 48 0.6× 20 389
Shereen F. Mossallam Egypt 12 225 0.8× 75 0.4× 84 0.7× 44 0.6× 66 0.9× 19 340
Amir Tavakoli Kareshk Iran 13 192 0.7× 124 0.7× 42 0.4× 9 0.1× 91 1.2× 39 495
Ülkü Karaman Türkiye 11 191 0.7× 52 0.3× 19 0.2× 14 0.2× 61 0.8× 101 498
Ana Paula Sampaio Feitosa Brazil 11 63 0.2× 106 0.6× 22 0.2× 20 0.3× 45 0.6× 26 306
John C. Meade United States 14 123 0.5× 243 1.4× 17 0.1× 24 0.3× 251 3.3× 23 608
Razieh Tavakoli Oliaee Iran 15 94 0.3× 311 1.8× 19 0.2× 7 0.1× 94 1.3× 39 565
Kamal Kamboj United States 11 43 0.2× 117 0.7× 37 0.3× 42 0.5× 135 1.8× 20 444
Nina McNair United States 15 387 1.4× 38 0.2× 9 0.1× 64 0.8× 126 1.7× 21 572
Andrea Schiefer Germany 13 72 0.3× 38 0.2× 81 0.7× 10 0.1× 32 0.4× 25 423

Countries citing papers authored by Eglal I. Amer

Since Specialization
Citations

This map shows the geographic impact of Eglal I. Amer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eglal I. Amer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eglal I. Amer more than expected).

Fields of papers citing papers by Eglal I. Amer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eglal I. Amer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eglal I. Amer. The network helps show where Eglal I. Amer may publish in the future.

Co-authorship network of co-authors of Eglal I. Amer

This figure shows the co-authorship network connecting the top 25 collaborators of Eglal I. Amer. A scholar is included among the top collaborators of Eglal I. Amer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eglal I. Amer. Eglal I. Amer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Eglal I., et al.. (2023). Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis. Tropical Medicine and Infectious Disease. 8(2). 106–106. 6 indexed citations
2.
Amer, Eglal I., et al.. (2023). Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?. PLoS neglected tropical diseases. 17(12). e0011776–e0011776. 6 indexed citations
3.
4.
Abou-El-Naga, Iman F., et al.. (2019). Biological and proteomic studies of Schistosoma mansoni with decreased sensitivity to praziquantel. Comparative Immunology Microbiology and Infectious Diseases. 66. 101341–101341. 20 indexed citations
5.
Eissa, Maha M., et al.. (2017). Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens. PLoS neglected tropical diseases. 11(8). e0005853–e0005853. 10 indexed citations
6.
Abou-El-Naga, Iman F., et al.. (2016). Total protein composition of young and adult Biomphalaria alexandrina snails with different compatibilities to Schistosoma mansoni infection. Revista de Biología Tropical. 64(4). 1747–57. 2 indexed citations
7.
Eissa, Maha M., et al.. (2016). Repositioning of chlorambucil as a potential anti-schistosomal agent. Acta Tropica. 166. 58–66. 11 indexed citations
8.
Eissa, Maha M., et al.. (2015). Could miltefosine be used as a therapy for toxoplasmosis?. Experimental Parasitology. 157. 12–22. 31 indexed citations
9.
Eissa, Maha M., Riham M. El‐Moslemany, Alyaa A. Ramadan, et al.. (2015). Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study. PLoS ONE. 10(11). e0141788–e0141788. 70 indexed citations
10.
11.
Amer, Eglal I., Maha M. Eissa, & Shereen F. Mossallam. (2014). Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis. Journal of Parasitic Diseases. 40(2). 475–484. 12 indexed citations
12.
Mossallam, Shereen F., et al.. (2014). Potentiated anti-microsporidial activity of Lactobacillus acidophilus CH1 bacteriocin using gold nanoparticles. Experimental Parasitology. 144. 14–21. 33 indexed citations
13.
Amer, Eglal I., Shereen F. Mossallam, & Hoda Mahrous. (2014). Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. Experimental Parasitology. 146. 52–63. 29 indexed citations
14.
15.
Ewaisha, Radwa, et al.. (2014). Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection. Experimental Parasitology. 145. 51–60. 18 indexed citations
16.
Mossallam, Shereen F., Eglal I. Amer, & Iman F. Abou-El-Naga. (2013). New scope on the relationship between rotifers and Biomphalaria alexandrina snails. Asian Pacific Journal of Tropical Biomedicine. 3(8). 595–603. 2 indexed citations
17.
Eissa, Maha M. & Eglal I. Amer. (2012). Giardia lamblia: A new target for miltefosine. International Journal for Parasitology. 42(5). 443–452. 23 indexed citations
18.
Eissa, Maha M., et al.. (2011). Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis. Experimental Parasitology. 128(4). 382–390. 27 indexed citations
19.
Saudi, Manal N., et al.. (2010). Synthesis and biological evaluation of a novel class as antileishmanial agent. Medicinal Chemistry Research. 21(2). 257–267. 13 indexed citations
20.
Eissa, Maha M., Mervat Z. El‐Azzouni, Eglal I. Amer, & Nahed Baddour. (2010). Miltefosine, a promising novel agent for schistosomiasis mansoni. International Journal for Parasitology. 41(2). 235–242. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mervat Z. El‐Azzouni Breakdown of academic impact, for papers by Shereen F. Mossallam Breakdown of academic impact, for papers by Amir Tavakoli Kareshk Breakdown of academic impact, for papers by Ülkü Karaman Breakdown of academic impact, for papers by Ana Paula Sampaio Feitosa Breakdown of academic impact, for papers by John C. Meade Breakdown of academic impact, for papers by Razieh Tavakoli Oliaee Breakdown of academic impact, for papers by Kamal Kamboj Breakdown of academic impact, for papers by Nina McNair Breakdown of academic impact, for papers by Andrea Schiefer
Rankless by CCL
2026